Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-23 of 23
» View latimes.com items only
    Jan 30, 2012 |Story| Los Angeles Times
  1. New Avastin tests add to confusion over use in breast cancer

    In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease. The reason: emerging evidence that the drug does not prolong life and also that it's been linked to serious side effects.
    In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease. The...

    Tags: Blood, Lymphatic System, Food and Drug Administration, Heart Attack, Diseases and Illnesses

  2. Dec 30, 2011 |Story| Baltimore Sun
  3. Avastin shown to slow ovarian cancer

    A new international study shows that treating ovarian cancer with Avastin delays the disease progression and may improve survival. The drug, generically called bevacizumab, seemed to keep the disease from returning for two months. It was delayed five...

    Tags: Medical Specialization, Blood, Ovarian Cancer, Drugs and Medicines, Health Treatments

  4. Dec 7, 2011 |Story| Petoskey News
  5. Big promise is seen in 2 new breast cancer drugs

    SAN ANTONIO (AP) — Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse. In a large international...

    Tags: Duke University, Blood, Novartis AG, Washington Hospital Center, Food and Drug Administration

  6. Nov 18, 2011 | Los Angeles Times
  7. Caughlin fire: 20 structures destroyed, thousands evacuated in Reno

    Nation Now
    Caughlin Fire: The out-of-control Caughlin Fire in Reno has destroyed 20 homes and forced 9,500 people to evacuate....
  8. Nov 18, 2011 | Los Angeles Times
  9. New drilling could bring highway money, GOP leaders say

    Nation Now
    Congressional Republican leaders are drafting legislation that would steer money from new offshore energy production into highway construction....
  10. Nov 18, 2011 | Los Angeles Times
  11. Killer Paul Rhoades executed by lethal injection in Idaho

    Nation Now
    Convicted killer Paul Ezra Rhoades executed in Idaho...
  12. Nov 18, 2011 |Story| Daily Press
  13. Health Notes: FDA revokes approval of Avastin for breast cancer treatment

    Here's the reaction of the National Breast Cancer Coalition (NBCC) to the news that the FDA has pulled approval of Avastin for breast cancer treatment.
    Here's the reaction of the National Breast Cancer Coalition (NBCC) to the news that the FDA has pulled approval of Avastin for breast cancer treatment. "The coalition applauds the FDA and Commissioner Margaret Hamburg for the decision to revoke the...

    Tags: Diseases and Illnesses, Breast Cancer, Margaret Hamburg, Health, Health Treatments

  14. Sep 20, 2011 |Story| Reuters
  15. Jun 30, 2011 |Story| KDAF-LTV
  16. FDA: Breast Cancer Drug Avastin Doesn't Work

    It's been a roller coaster ride for the breast cancer drug Avastin--the FDA gave accelerated approval just three years ago but now an advisory panel had ruled that it's not safe or effective in treating breast cancer.
    The 33 News
    It's been a roller coaster ride for the breast cancer drug Avastin--the FDA gave accelerated approval just three years ago but now an advisory panel had ruled that it's not safe or effective in treating breast cancer. Dr. Hania Alaidroos of Arbor Green...

    Tags: Dallas, Drugs and Medicines, Food and Drug Administration, Diseases and Illnesses, Breast Cancer

  17. Jun 28, 2011 | Los Angeles Times
  18. Avastin: There's the truth and then there's the politics behind the cancer drug [The conversation]

    Opinion L.A.
    Avastin: The FDA goes up against drug manufacturer Genentech with regards to the late-stage cancer drug....
  19. Jul 23, 2010 |Resource Link| Los Angeles Times
< Previous1  2 
Advertisement
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Bevacizumab (drug) Photos
A sign is displayed in front of the Genentech headquart...
(December 13, 2012)
A sign is displayed in front of the Genentech headquarters July 14, 2008 in South San Francisco, California. This company relied on the popularity of its cancer drug Avastin to boost profits.
FDA withdraws approval of Avastin for breast cancer pat...
(November 18, 2011)
the cancer drug avastin
, saying studies have failed to prove the drug's effect...
(July 1, 2011)
FDA panel rejects Avastin for breast cancer, but Medicare will still pay for it -- and Provenge